ICU Medical, Inc.
ICUI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2,382,046 | $2,259,126 | $2,279,997 | $1,316,308 |
| % Growth | 5.4% | -0.9% | 73.2% | – |
| Cost of Goods Sold | $1,557,264 | $1,519,253 | $1,582,236 | $824,818 |
| Gross Profit | $824,782 | $739,873 | $697,761 | $491,490 |
| % Margin | 34.6% | 32.8% | 30.6% | 37.3% |
| R&D Expenses | $88,615 | $85,344 | $92,984 | $47,498 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $638,762 | $606,693 | $608,345 | $302,583 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $54,441 | $25,011 | $39,330 | $18,164 |
| Operating Expenses | $781,818 | $717,048 | $740,659 | $368,245 |
| Operating Income | $42,964 | $22,825 | -$42,898 | $123,245 |
| % Margin | 1.8% | 1% | -1.9% | 9.4% |
| Other Income/Exp. Net | -$108,976 | -$101,124 | -$71,511 | -$59 |
| Pre-Tax Income | -$66,012 | -$78,299 | -$114,409 | $123,186 |
| Tax Expense | $51,676 | -$48,644 | -$40,123 | $20,051 |
| Net Income | -$117,688 | -$29,655 | -$74,286 | $103,135 |
| % Margin | -4.9% | -1.3% | -3.3% | 7.8% |
| EPS | -4.83 | -1.23 | -3.11 | 4.86 |
| % Growth | -292.7% | 60.5% | -164% | – |
| EPS Diluted | -4.83 | -1.23 | -3.11 | 4.74 |
| Weighted Avg Shares Out | 24,388 | 24,091 | 23,868 | 21,206 |
| Weighted Avg Shares Out Dil | 24,388 | 24,091 | 23,868 | 21,781 |
| Supplemental Information | – | – | – | – |
| Interest Income | $10,788 | $7,508 | $4,430 | $2,840 |
| Interest Expense | $106,541 | $102,727 | $70,805 | $858 |
| Depreciation & Amortization | $2,435 | $228,774 | $235,151 | $99,292 |
| EBITDA | $42,964 | $253,202 | $191,547 | $223,458 |
| % Margin | 1.8% | 11.2% | 8.4% | 17% |